Related Experiment Video
Updated: Aug 15, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Treatment strategies for highly treatment-experienced HIV-infected patients
1Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA, USA. a.luber@earthlink.net
Abstract:
The management of highly treatment-experienced HIV-infected patients is often complicated by baseline antiretroviral drug resistance, patient intolerabilities, drug-drug interactions and quality-of-life issues; which are all factors that can limit the ability to construct a potent regimen. The mainstay of treatment has been to use new agents with activity against resistant virus. New agents, such as enfuvirtide and tipranavir/ritonavir, have shown promising results in highly active antiretroviral treatment regimens among patients with extensive treatment histories and resistance profiles, especially when used in combination with other active agents. Other strategies include mega-highly active antiretroviral treatment, double-boosted protease inhibitors, structured treatment interruptions and maintaining a replicative compromised virus. The future development of newer agents with activity against resistant virus is desperately needed, and many new compounds and classes of antiretrovirals are currently being investigated.
Related Concept Videos
Retrovirus Life Cycles
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

